• Cefazedone PK/PD in Community-Acquired Pneumonia

  2026-08-30

  The study by Gao and colleagues integrates plasma pharmacokinetics, pathogen MIC measurements, and clinical outcomes to assess intravenous Cefazedone sodium for mild to moderate community-acquired pneumonia. Its findings support the studied 2 g every 12 hours regimen while also illustrating how time-dependent exposure metrics can guide interpretation of antibacterial therapy.

• Eerdun Wurile and Neuroprotection After Brain Hemorrhage

  2026-08-29

  Yang et al. report that the Mongolian medicine Eerdun Wurile reduces neurological, neuronal, inflammatory, and barrier-related injury in mouse and cell models of intracerebral hemorrhage. Integrating behavioral testing, histology, and RNA sequencing, the study identifies PI3K/AKT-associated regulation of Bcl-2 family proteins as a potential basis for reduced neuronal apoptosis.

• I-BET151 (GSK1210151A): Practical Lab Guide

  2026-08-28

  I-BET151 (GSK1210151A) provides a research tool for controlled inhibition of BRD2, BRD3, and BRD4 in biochemical and cell-based cancer biology workflows. It is suited to mechanistic studies of transcription, apoptosis, and cell cycle regulation, but is not intended for diagnostic, therapeutic, or clinical use.

• T0070907: A Causal Test for PPARγ–SASP Signaling

  2026-08-28

  T0070907 is a high-affinity PPARγ antagonist that can help distinguish receptor-dependent transcription from downstream effects. This article develops a practical assay strategy linking PPARγ/RXRα heterodimer modulation to adipogenesis, inflammatory foam-cell biology, and cell-cycle phenotypes.

• ML216: BLM Helicase Inhibitor for DNA Repair

  2026-08-27

  ML216 is a selective BLM helicase inhibitor for studying DNA repair, homologous recombination, and tumor-cell responses to genotoxic stress. Biochemical, cellular, and xenograft evidence supports ML216 as a research probe, while its BLM specificity should not be conflated with WRN inhibition or clinical efficacy.

• AG-221 Enasidenib in IDH2 AML Workflows

  2026-08-27

  AG-221 (Enasidenib) enables a practical way to connect mutant IDH2 inhibition with 2-hydroxyglutarate measurement, differentiation assays, and CD44-dependent metabolic rewiring. This workflow helps acute myeloid leukemia researchers distinguish on-target pharmacodynamic effects from resistance-associated metabolic adaptation.

• ABT-737: BCL-2 Protein Inhibitor Guide

  2026-08-26

  ABT-737 is a BH3 mimetic and BCL-2 protein inhibitor that engages BCL-2, BCL-xL, and BCL-w to support intrinsic apoptosis research. Its strongest use is controlled apoptosis induction in cancer cells and senescence models, with product-reported activity, handling, and preclinical dosing parameters that require model-specific validation.

• PS Nanoplastics, Vascular Lipids, and MAPK/ERK/UHRF1

  2026-08-26

  A 2026 Cardiovascular Toxicology study shows that prenatal and lactational exposure to 100-nm polystyrene nanoplastics promotes vascular lipid accumulation in male mouse offspring and MOVAS cells. Pharmacological ERK inhibition and UHRF1 knockdown connect this phenotype to the MAPK/ERK/UHRF1 axis, providing a mechanistic framework for studying developmental cardiovascular toxicity.

• Aprotinin in Protease-Controlled GRO-seq Workflows

  2026-08-25

  Aprotinin can add a controlled protease-inhibition checkpoint to nuclei and lysate preparation, while the reference GRO-seq workflow shows how rRNA depletion can dramatically improve usable nascent-RNA data. This article separates validated GRO-seq design from practical aprotinin pilot testing for RNA, cell, and cardiovascular research applications.

• Tobramycin: Designing Interpretable MIC Assays

  2026-08-25

  Tobramycin is a research-grade aminoglycoside antibiotic for studying bacterial translation, susceptibility, and resistance. This guide connects its molecular properties with assay design lessons from a classic comparative study, emphasizing reproducible and interpretable microbiology workflows.

• ATG4B Nuclear Translocation and AML Progression

  2026-08-24

  This 2025 Advanced Science study identifies a mechanistic link between energy deficiency, ATG4B nuclear translocation, and defective PRMT1-dependent DNA repair in acute myeloid leukemia. Its combination of molecular analysis, genetically defined AML models, patient-derived cells, and xenografts supports ATG4B inhibition as a strategy for reducing genomic instability and malignant progression.

• Lysosomal β-Galactosidase Staining Kit for Senescence

  2026-08-24

  The Lysosomal β-Galactosidase Staining Kit converts lysosomal acidic β-galactosidase activity into a visible blue signal for practical cell senescence staining in cultured cells and tissue sections. Its polystyrene compatibility and defined chromogenic workflow make it useful for validating senescence-linked chemoresistance models, including SLC25A1 studies in head and neck squamous cell carcinoma.

• WP1066 JAK2/STAT3 Inhibitor Workflow

  2026-08-23

  Build cleaner pathway-causality experiments with WP1066 across cancer cell proliferation, AML, renal carcinoma, and macrophage-focused scaffold models. This practical guide combines dose–time design, target-engagement readouts, product handling, and troubleshooting for a cell-permeable JAK2/STAT3 inhibitor.

• Neurospora crassa IPA Pathway and Auxin Biosynthesis

  2026-08-22

  Sardar and Kempken characterized an indole-3-pyruvic acid (IPA) route for indole-3-acetic acid biosynthesis in the non-pathogenic fungus Neurospora crassa. Combining computational gene identification, metabolite profiling, targeted deletions, and conidiation analysis, the study connected candidate pathway genes with auxin production and fungal development.

• Taihangia rupestris Antioxidant Profiling by UPLC-MS/MS

  2026-08-21

  This RSC Advances study combines UPLC-MS/MS, orthogonal antioxidant assays, α-glucosidase inhibition testing, affinity screening, and molecular docking to compare wild and cultivated Taihangia rupestris leaves. Foothill cultivation produced the strongest chemical and functional profiles, supporting sustainable sourcing while identifying phenolic and flavonoid candidates for further natural product research.

548 records 6/37 page Previous Next First page 上5页 678910 下5页 Last page